Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Y / Y Equity Change	13.82 %	9.6 %	19.72 %	15.89 %	7.49 %
Y / Y Net Income Change	-15 %	79.56 %	-18.26 %	64.1 %	-35.42 %
Return On Equity	16.47 %	22.06 %	13.46 %	19.72 %	13.92 %

GMAB all Ratios >> Back to GMAB Management Effectiveness >> See Quarterly GMAB Return On Equity

You need to upgrade your Flash Player

Roe Comment

In (Dec 31 2025) ROE decreased compare to previous year to 16.47 %, due to detoriation of net income.

Financial Statements
Genmab A's Equity	$ 5,847 Millions	Annual GMAB's Balance sheet
Genmab A's Annual Income	$ 963 Millions	Annual GMAB's Income Statement
Where are GMAB's Income coming from?		Visit GMAB's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.